Ingrid Kreissig

Summary

Affiliation: University of Heidelberg
Country: Germany

Publications

  1. ncbi Surgical techniques for repair of primary retinal detachment: Part II. Comparison of present techniques in relation to morbidity
    Ingrid Kreissig
    Department of Ophthalmology, University of Mannheim Heidelberg, Germany
    Folia Med (Plovdiv) 52:5-11. 2010
  2. ncbi Surgical techniques for repair of primary retinal detachment: part I. Review of their development during the last 80 years
    Ingrid Kreissig
    Department of Ophthalmology, University of Mannheim Heidelberg, Germany
    Folia Med (Plovdiv) 51:5-11. 2009
  3. ncbi Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion
    Robert F Degenring
    Department of Ophthalmology, Faculty for Clinical Medicine Mannheim, Ruprecht-Karls-University Heidelberg, Germany
    Acta Ophthalmol Scand 81:548-50. 2003
  4. ncbi Duration of the effect of intravitreal triamcinolone acetonide in eyes with exudative age-related macular degeneration
    Jost B Jonas
    Department of Ophthalmology, Faculty of Clinical Medicine Mannheim of the Ruprecht-Karls-University of Heidelberg, Germany
    J Ocul Pharmacol Ther 22:194-9. 2006
  5. ncbi Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases
    Jost B Jonas
    Department of Ophthalmology, Faculty of Clinical Medicine Mannheim, Ruprecht Karls University of Heidelberg, Germany
    Prog Retin Eye Res 24:587-611. 2005
  6. ncbi Predictive factors for visual acuity after intravitreal triamcinolone treatment for diabetic macular edema
    Jost B Jonas
    Department of Ophthalmology, Faculty of Clinical Medicine Mannheim of the University Heidelberg, Mannheim
    Arch Ophthalmol 123:1338-43. 2005
  7. ncbi Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonide
    Jost B Jonas
    Department of Ophthalmology, Faculty of Clinical Medicine Mannheim, Ruprecht Karls University of Heidelberg, Theodor Kutzer Ufer 1 3, 68167 Mannheim, Germany
    Am J Ophthalmol 141:579-80. 2006
  8. ncbi Visual acuity change after intravitreal bevacizumab for exudative age-related macular degeneration in relation to subfoveal membrane type
    Jost B Jonas
    Department of Ophthalmology, Faculty of Clinical Medicine Mannheim, University of Heidelberg, Mannheim, Germany
    Acta Ophthalmol Scand 85:563-5. 2007
  9. ncbi Intravitreal bevacizumab versus triamcinolone acetonide for exudative age-related macular degeneration
    Jost B Jonas
    Department of Ophthalmology, Medical Faculty Mannheim of the Ruprecht Karl University, Heidelberg, Germany
    Ophthalmic Res 41:21-7. 2009
  10. ncbi Intraocular pressure elevation after intravitreal triamcinolone acetonide injection
    Jost B Jonas
    Department of Ophthalmology, Faculty of Clinical Medicine Mannheim of the University Heidelberg, Heidelberg, Germany
    Ophthalmology 112:593-8. 2005

Detail Information

Publications20

  1. ncbi Surgical techniques for repair of primary retinal detachment: Part II. Comparison of present techniques in relation to morbidity
    Ingrid Kreissig
    Department of Ophthalmology, University of Mannheim Heidelberg, Germany
    Folia Med (Plovdiv) 52:5-11. 2010
    ..o.) with pneumatic retinopexy or vitrectomy. The results are similar ranging between 94% and 99% attachment, however, the difference lies in their morbidity and socioeconomic implications which will be compared...
  2. ncbi Surgical techniques for repair of primary retinal detachment: part I. Review of their development during the last 80 years
    Ingrid Kreissig
    Department of Ophthalmology, University of Mannheim Heidelberg, Germany
    Folia Med (Plovdiv) 51:5-11. 2009
    ..To analyse the evolution of surgical approaches to repairing primary rhegmatogenous retinal detachment and the issues which had determined the changes starting from 1929 to the present...
  3. ncbi Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion
    Robert F Degenring
    Department of Ophthalmology, Faculty for Clinical Medicine Mannheim, Ruprecht-Karls-University Heidelberg, Germany
    Acta Ophthalmol Scand 81:548-50. 2003
  4. ncbi Duration of the effect of intravitreal triamcinolone acetonide in eyes with exudative age-related macular degeneration
    Jost B Jonas
    Department of Ophthalmology, Faculty of Clinical Medicine Mannheim of the Ruprecht-Karls-University of Heidelberg, Germany
    J Ocul Pharmacol Ther 22:194-9. 2006
    ....
  5. ncbi Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases
    Jost B Jonas
    Department of Ophthalmology, Faculty of Clinical Medicine Mannheim, Ruprecht Karls University of Heidelberg, Germany
    Prog Retin Eye Res 24:587-611. 2005
    ..Intravitreal triamcinolone acetonide may offer a possibility for adjunctive treatment of intraocular edematous and neovascular disorders. One has to take into account the side-effects and the lack of long-term follow-up observations...
  6. ncbi Predictive factors for visual acuity after intravitreal triamcinolone treatment for diabetic macular edema
    Jost B Jonas
    Department of Ophthalmology, Faculty of Clinical Medicine Mannheim of the University Heidelberg, Mannheim
    Arch Ophthalmol 123:1338-43. 2005
    ..To evaluate which factors influence maximum gain in best-corrected visual acuity after intravitreal injection of triamcinolone acetonide as treatment for diffuse diabetic macular edema...
  7. ncbi Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonide
    Jost B Jonas
    Department of Ophthalmology, Faculty of Clinical Medicine Mannheim, Ruprecht Karls University of Heidelberg, Theodor Kutzer Ufer 1 3, 68167 Mannheim, Germany
    Am J Ophthalmol 141:579-80. 2006
    ..To evaluate the rate of infectious and noninfectious endophthalmitis after intravitreal injection of a high-dosage of triamcinolone acetonide...
  8. ncbi Visual acuity change after intravitreal bevacizumab for exudative age-related macular degeneration in relation to subfoveal membrane type
    Jost B Jonas
    Department of Ophthalmology, Faculty of Clinical Medicine Mannheim, University of Heidelberg, Mannheim, Germany
    Acta Ophthalmol Scand 85:563-5. 2007
    ..To examine an association between the subfoveal neovascular membrane type and visual acuity change after intravitreal bevacizumab injection for exudative age-related macular degeneration (AMD)...
  9. ncbi Intravitreal bevacizumab versus triamcinolone acetonide for exudative age-related macular degeneration
    Jost B Jonas
    Department of Ophthalmology, Medical Faculty Mannheim of the Ruprecht Karl University, Heidelberg, Germany
    Ophthalmic Res 41:21-7. 2009
    ..To compare an intravitreal high-dose injection of triamcinolone acetonide with an intravitreal injection of bevacizumab for the treatment of progressive exudative age-related macular degeneration (AMD)...
  10. ncbi Intraocular pressure elevation after intravitreal triamcinolone acetonide injection
    Jost B Jonas
    Department of Ophthalmology, Faculty of Clinical Medicine Mannheim of the University Heidelberg, Heidelberg, Germany
    Ophthalmology 112:593-8. 2005
    ..To report on intraocular pressure (IOP) after intravitreal injections of triamcinolone acetonide...
  11. ncbi Safety of intravitreal high-dose reinjections of triamcinolone acetonide
    Jost B Jonas
    Department of Ophthalmology and Eye Hospital, Medical Faculty Mannheim of the Ruprecht Karls University Heidelberg, Germany
    Am J Ophthalmol 138:1054-5. 2004
    ..To report side effects after intravitreal high-dose reinjections of triamcinolone acetonide...
  12. ncbi Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema
    Jost B Jonas
    Department of Ophthalmology, Faculty of Clinical Medicine Mannheim, University of Heidelberg, Heidelberg, Germany
    Am J Ophthalmol 138:158-60. 2004
    ..To evaluate the duration of the effect of intravitreal triamcinolone acetonide on visual acuity in patients with diffuse diabetic macular edema...
  13. ncbi Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration
    Jost B Jonas
    Department of Ophthalmology, Faculty of Clinical Medicine of Mannheim, University of Heidelberg, Heidelberg, Germany
    Arch Ophthalmol 122:218-22. 2004
    ..To evaluate the outcome of repeated intravitreal injections of triamcinolone acetonide for the treatment of exudative age-related macular degeneration...
  14. ncbi Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema
    Jost B Jonas
    Department of Ophthalmology, Faculty for Clinical Medicine Mannheim, Ruprecht Karls University, Heidelberg, Germany
    Am J Ophthalmol 136:384-6. 2003
    ..To report the clinical outcome of patients undergoing intravitreal injection of triamcinolone acetonide as treatment of long-standing cystoid macular edema after phacoemulsification...
  15. ncbi Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion
    Robert F Degenring
    Department of Ophthalmology, Faculty for Clinical Medicine Mannheim, Ruprecht-Karls-University, Heidelberg, Germany
    Acta Ophthalmol Scand 81:399-401. 2003
  16. ncbi [Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide]
    Jost B Jonas
    Universitats Augenklinik, Fakultät für Klinische Medizin Mannheim der Ruprecht Karls Universität Heidelberg
    Klin Monbl Augenheilkd 220:384-90. 2003
    ..Recent studies have suggested that intravitreal triamcinolone acetonide may be a therapeutical possibility for treating of various intraocular neovascular, oedematous and proliferative diseases...
  17. ncbi Secondary chronic open-angle glaucoma after intravitreal triamcinolone acetonide
    Jost B Jonas
    , Mannheim, Germany
    Arch Ophthalmol 121:729-30. 2003
  18. ncbi Intravitreal injection of triamcinolone for diffuse diabetic macular edema
    Jost B Jonas
    Department of Ophthalmology and the Eye Hospital, Faculty for Clinical Medicine Mannheim, Ruprecht Karls University, Heidelberg, Germany
    Arch Ophthalmol 121:57-61. 2003
    ..To evaluate the clinical outcome of an intravitreal injection of triamcinolone acetonide as treatment of diffuse diabetic macular edema...
  19. ncbi Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion
    Jost B Jonas
    Department of Ophthalmology and Eye Hospital, Faculty for Clinical Medicine, Mannheim, Ruprecht Karls University Heidelberg, Germany
    Graefes Arch Clin Exp Ophthalmol 240:782-3. 2002
    ..To report the clinical outcome of a patient receiving an intravitreal injection of triamcinolone acetonide as treatment of bilateral, long-standing, cystoid macular edema due to central retinal vein occlusion...
  20. ncbi [Rhegmatogenous PVR detachment: long-term results after extraocular minimal scleral buckling]
    Nelly Sivkova
    Department of Ophthalmology, Higher Medical Institute, Plovdiv, Bulgarien, Germany
    Klin Monbl Augenheilkd 219:519-22. 2002
    ..To present the long-term anatomical and functional results and the dynamics of proliferative vitreoretinopathy (PVR) after precise segmental scleral buckling without drainage, known as extraocular minimal surgery...